Neuroprotective drugs in traumatic CNS injury

Open Drug Discovery Journal

Volumn 2, Issue SPEC. ISS.3, 2010, Pages 174-180

  Samantaray, Supriti ^a   Thakore, Nakul P ^a   Matzelle, Denise D ^a   Varma, Abhay ^a   Ray, Swapan K ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Melatonin; Neuroprotective agents; Spinal cord injury

Indexed keywords

ARMODAFINIL; CITICOLINE; DEFEROXAMINE; DEXANABINOL; ERYTHROPOIETIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MELATONIN; METHYLPREDNISOLONE; MODAFINIL; PHENYTOIN; RECOMBINANT ERYTHROPOIETIN; RILUZOLE; RIVASTIGMINE; TIRILAZAD; TOPIRAMATE;

ACUTE DISEASE; BRAIN EDEMA; BRAIN ISCHEMIA; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENCEPHALOMALACIA; EPILEPSY; FATIGUE; HUMAN; MOLECULAR PATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY;

EID: 84863902240     PISSN: None     EISSN: 18773818     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Lindsey, R.Z.G.S.P. Injury to the vertebrae and spinal cord. In Trauma; Moore Ef, Dv; Mattox, Kl. Eds.; McGraw-Hill, Medical Publication Division: New York, 2003, pp. 459-492.
2. Saatman, K.E.; Duhaime, A.C.; Bullock, R.; Maas, A.I.; Valadka, A.; Manley, G.T.; Workshop scientific team and advisory panel members. Classification of traumatic brain injury for targeted therapies. J. Neurotrauma, 2008, 25, 719-738.
3. Neuroprotective Agents Second International Conference. Slikker, W.J.; Andrews, R.J.; Trembly, B. Eds.; The New York Academy of Sciences, 1995.
4. Neuroprotective Agents Third International Conference. Slikker W.J. Ed.; The New York Academy of Sciences, 1997.
5. Neuroprotective Agents Fourth International Conference. Trembly, B.; Slikker, W.J. Eds.; The New York Academy of Sciences, 1999.
6. Neuroprotective Agents Fifth International Conference. Slikker W.J.; Trembly, B. Eds.; The New York Academy of Sciences, 2001.
7. Neuroprotective Agents Sixth International Conference. Slikker, W.J.; Andrews R.J.; Trembly B. Eds. The New York Academy of Sciences, 2003.
8. Neuroprotective Agents Seventh International Conference. Slikker, W.J.; Andrews, R.J.; Trembly, B. Eds.; The New York Academy of Sciences, 2005.
9. Neuroprotective Agents Eighth International Conference. Slikker W.J.; Andrews R.J.; Trembly, B. Eds.; The New York Academy of Sciences, 2007.
10. Ray, S.K.; Banik, N.L. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr. Drug Targets CNS Neurol. Disord., 2003, 2, 173-189.
11. Vasudevan, N.; Pfaff, D.W. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol., 2008, 29, 238-257.
12. Marino, M.; Galluzzo, P.; Ascenzi, P. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genomics, 2006, 7, 497-508.
13. Brann, D.W.; Dhandapani, K.; Wakade, C.; Mahesh, V.B.; Khan, M.M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids, 2007, 72, 381-405.
14. Straub, R.H. The complex role of estrogens in inflammation. Endocr. Rev., 2007, 28, 521-574.
15. Miller, V.M.; Duckles, S.P. Vascular actions of estrogens: functional implications. Pharmacol. Rev., 2008, 60, 210-241.
16. Kelly, M.J.; Levin, E.R. Rapid actions of plasma membrane estrogen receptors. Trends in endocrinology and metabolism: TEM, 2001, 12, 152-156.
17. Nilsen, J. Estradiol and neurodegenerative oxidative stress. Front. Neuroendocrinol., 2008, 29, 463-475.
18. J.A. Novel aspects of estrogen action. J. Soc. Gynecol. Investig., 2000, 7(1 Suppl), S8-S9.
19. Sur, P.; Sribnick, E.A.; Wingrave, J.M.; Nowak, M.W.; Ray, S.K.; Banik, N.L. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res., 2003, 971, 178-188.
20. Sribnick, E.A.; Ray, S.K.; Banik, N.L. Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptormediated mechanism. Neuroscience, 2006, 137, 197-209.
21. Sribnick, E.A.; Ray, S.K.; Nowak, M.W.; Li, L.; Banik, N.L. 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J. Neurosci. Res., 2004, 76, 688-696.
22. Sribnick, E.A.; Matzelle, D.D.; Ray, S.K.; Banik, N.L. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J. Neurosci. Res., 2006, 84, 1064-1075.
23. Sribnick, E.A.; Wingrave, J.M.; Matzelle, D.D.; Wilford, G.G; Ray, S.K.; Banik, N.L. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J. Neurosci. Res., 2005, 82, 283-293.
24. Sribnick, E.A.; Samantaray, S.; Ray, S.K. et al. Estrogen improves locomotor function following spinal cord injury. In: International Society for Neurochemistry. J. Neurochem., 2007, p. 203.
25. Islamov, R.R.; Hendricks, W.A.; Katwa, L.C.; McMurray, R.J.; Pak, E.S.; Spanier, N.S.; Murashov, A.K. Effect of 17 betaestradiol on gene expression in lumbar spinal cord following sciatic nerve crush injury in ovariectomized mice. Brain Res., 2003, 966, 65-75.
26. Yune, T.Y.; Kim, S.J.; Lee, S.M.; Lee, Y.K.; Oh, Y.J.; Kim, Y.C.; Markelonis, G.J.; Oh, T.H. Systemic administration of 17betaestradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma, 2004, 21, 293-306.
27. Yune, T.Y.; Park, H.G.; Lee, J.Y.; Oh, T.H. Estrogen-induced Bcl- 2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J. Neurotrauma, 2008, 25, 1121-1131.
28. Webb, A.A.; Chan, C.B.; Brown, A.; Saleh, T.M. Estrogen reduces the severity of autonomic dysfunction in spinal cord-injured male mice. Behav. Brain Res., 2006, 171(2), 338-349.
29. Chaovipoch, P.; Jelks, K.A.; Gerhold, L.M.; West, E.J.; Chongthammakun, S.; Floyd, C.L. 17beta-estradiol is protective in spinal cord injury in post- and pre-menopausal rats. J. Neurotrauma, 2006, 23(6), 830-852.
30. Cuzzocrea, S.; Genovese, T.; Mazzon, E.; Esposito, E.; Di Paola, R.; Muià, C.; Crisafulli, C.; Peli, A.; Bramanti, P.; Chaudry, I.H. Effect of 17beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock, 2008, 29(3), 362-371.
31. Ritz, M.F.; Hausmann, O.N. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res., 2008, 1203, 177-188.
32. Swartz, K.R.; Fee, D.B.; Joy, K.M.; Roberts, K.N.; Sun, S.; Scheff, N.N.; Wilson, M.E.; Scheff, S.W. Gender differences in spinal cord injury are not estrogen-dependent. J. Neurotrauma, 2007, 24(3), 473-480.
33. Roof, R.L.; Hall, E.D. Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats. J. Neurotrauma, 2000, 17, 1155-1169.
34. Samantaray, S.; Sribnick, E.A.; Das, A.; Knaryan, V.H.; Matzelle, D.D.; Yallapragada, A.V.; Reiter, R.J.; Ray, S.K.; Banik, N.L. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J. Pineal. Res., 2008, 44, 348-357.
35. Samantaray, S.; Das, A.; Thakore, N.P.; Matzelle, D.D.; Reiter, R.J.; Ray, S.K.; Banik, N.L. Therapeutic potential of melatonin in traumatic central nervous system injury. J. Pineal. Res., 2009, 47, 134-142.